Metformin or Acarbose Treatment Significantly Reduced Albuminuria in Patients with Newly Diagnosed Type 2 Diabetes Mellitus and Low-Grade Albuminuria

被引:8
作者
Pan, Qingrong [1 ]
Xu, Yuan [1 ]
Yang, Ning [1 ]
Gao, Xia [1 ]
Liu, Jia [1 ]
Yang, Wenying [2 ]
Wang, Guang [1 ]
机构
[1] Capital Med Univ, Beijing Chaoyang Hosp, Dept Endocrinol, Beijing, Peoples R China
[2] China Japan Friendship Hosp, Dept Endocrinol, Beijing, Peoples R China
来源
MEDICAL SCIENCE MONITOR | 2018年 / 24卷
基金
中国国家自然科学基金;
关键词
Acarbose; Albuminuria; Diabetes Mellitus; Type; 2; Metformin; GLOMERULAR-FILTRATION-RATE; CHRONIC KIDNEY-DISEASE; CARDIOVASCULAR-DISEASE; RISK-FACTORS; ALL-CAUSE; MICROALBUMINURIA; ASSOCIATION; POPULATION; DEATH; ATHEROSCLEROSIS;
D O I
10.12659/MSM.911979
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: A urine albumin to creatinine ratio (UACR) >30 mg/g is considered to represent albuminuria, but in type 2 diabetes mellitus, even low-grade albuminuria is associated with increased risk of cardiovascular disease. This study aimed to investigate the effects of metformin and acarbose treatment on urine albumin excretion in Chinese patients with newly diagnosed diabetes and low-grade albuminuria. Material/Methods: Patients with newly diagnosed diabetes (n=589) were divided into Group I (with a baseline UACR <10 mg/g) (n=331), and Group II (with a baseline UACR of 10-30 mg/g) (n=258). Following 48 weeks of treatment with metformin or acarbose, the UACR, blood pressure, body mass index (BMI), blood glucose, lipid profiles, and homeostasis model assessment of insulin resistance (HOMA-IR) were compared. Results: Baseline diastolic blood pressure, levels of blood glucose and low-density lipoprotein cholesterol (LDL-C), and HOMA-IR were significantly increased in Group II compared with Group I (all P<0.05). In Group II, both metformin and acarbose treatment significantly reduced the UACR (P<0.001); the effect was significantly greater following acarbose treatment compared with metformin treatment (P<0.05). In Group I, neither metformin nor acarbose treatment significantly changed the UACR, but both Group I and Group II showed a significant and comparable reduction in BMI, blood glucose, blood pressure, and HOMA-IR. Conclusions: In a group of Chinese patients with newly diagnosed type 2 diabetes mellitus, low-grade albuminuria (baseline UACR of 10-30 mg/g) was associated with metabolic factors before treatment. Treatment with either metformin or acarbose significantly reduced albumin excretion.
引用
收藏
页码:8941 / 8949
页数:9
相关论文
共 34 条
  • [1] Standards of Medical Care in Diabetes-2014
    不详
    [J]. DIABETES CARE, 2014, 37 : S14 - S80
  • [2] [Anonymous], PLOS ONE
  • [3] Fenofibrate reduces progression to microalbuminuria over 3 years in a placebo-controlled study in type 2 diabetes: Results from the Diabetes Atherosclerosis Intervention Study (DAIS)
    Ansquer, JC
    Foucher, C
    Rattier, S
    Taskinen, MR
    Steiner, G
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2005, 45 (03) : 485 - 493
  • [4] Nutrient intake among Chinese women living in Shanghai, China
    Chen, Zhi
    Shu, Xiao Ou
    Yang, Gong
    Li, Honglan
    Li, Qi
    Gao, Yu-Tang
    Zheng, Wei
    [J]. BRITISH JOURNAL OF NUTRITION, 2006, 96 (02) : 393 - 399
  • [5] Levels of albuminuria and risk of developing macroalbuminuria in type 2 diabetes: historical cohort study
    Chida, Shoma
    Fujita, Yoshikuni
    Ogawa, Akifumi
    Hayashi, Akinori
    Ichikawa, Raishi
    Kamata, Yuji
    Takeuchi, Akihiro
    Takano, Koji
    Shichiri, Masayoshi
    [J]. SCIENTIFIC REPORTS, 2016, 6
  • [6] Lowering the threshold for defining micro albuminuria: Effects of a lifestyle-metformin intervention in obese "Normoalbuminuric" non-diabetic subjects
    Cubeddu, Luigi X.
    Alfieri, Anna B.
    Hoffmann, Irene S.
    [J]. AMERICAN JOURNAL OF HYPERTENSION, 2008, 21 (01) : 105 - 110
  • [7] Albuminuria: A target for treatment of type 2 diabetic nephropathy
    de Zeeuw, Dick
    [J]. SEMINARS IN NEPHROLOGY, 2007, 27 (02) : 172 - 181
  • [8] Association between high-normal albuminuria and risk factors for cardiovascular and renal disease in essential hypertensive men
    Dell'Omo, G
    Penno, G
    Giorgi, D
    Di Bello, V
    Mariani, M
    Pedrinelli, R
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2002, 40 (01) : 1 - 8
  • [9] Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals
    Gerstein, HC
    Mann, JFE
    Yi, QL
    Zinman, B
    Dinneen, SF
    Hoogwerf, B
    Hallé, JP
    Young, J
    Rashkow, A
    Joyce, C
    Nawaz, S
    Yusuf, S
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (04): : 421 - 426
  • [10] Diagnosis and management of the metabolic syndrome - An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement
    Grundy, SM
    Cleeman, JI
    Daniels, SR
    Donato, KA
    Eckel, RH
    Franklin, BA
    Gordon, DJ
    Krauss, RM
    Savage, PJ
    Smith, SC
    Spertus, JA
    Costa, F
    [J]. CIRCULATION, 2005, 112 (17) : 2735 - 2752